| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |